2026-01-12 - Analysis Report
**Teladoc Health Inc (TDOC) Financial Report**
==============================================

### Overview
Teladoc Health Inc, a telemedicine service provider, experienced significant fluctuations in its stock performance and financial metrics.

### Return Rate Comparison
----------------------------------------

- **Rate vs VOO**: Teladoc Health Inc (TDOC) underperformed S&P 500 (VOO) by -156.50 points, which is - 0.50% of the maximum-minimum range.

- **Cumulative Return**
    - TDOC: -62.50%
    - VOO: 94.03%

### Alpha, Beta Analysis
---------------------------

| Year       | CAGR | MDD | Alpha | Beta | Cap(B) |
|------------|------|-----|-------|------|--------|
| 2016-2018  | 74.0%| 52.9%| 71.0% | 1.7  | 8.8B   |
| 2017-2019  | 119.0%| 52.9%| 101.0%| 1.8  | 14.9B  |
| 2018-2020  | 87.0%| 52.9%| 66.0% | 0.7  | 35.5B  |
| 2019-2021  | -84.0%| 60.6%| -127.0%| 0.5  | 16.3B  |
| 2020-2022  | -246.0%| 83.0%| -244.0%| 0.8  | 4.2B   |
| 2021-2023  | -302.0%| 83.0%| -303.0%| 1.9  | 3.8B   |
| 2022-2024  | -87.0%| 72.3%| -107.0%| 1.9  | 1.6B   |
| 2023-2025  | -34.0%| 65.6%| -96.0% | 1.7  | 1.2B   |

### Recent Stock Price Fluctuations
------------------------------------------

- **5-day SMA**: $7.58
- **20-day SMA**: $7.31
- **60-day SMA**: $7.68

### Recent Technical Indicators
------------------------------

- **RSI**: 57.21
- **PPO**: 0.87
- **MRI (Market Risk Indicator)**: 0.70
    - Risk Level: Medium

- **Delta_Previous_Relative_Divergence**: -0.20 (-): worsening
- **7-day Rank change**: 1 (+): rank up
- **7-day Dynamic Expected Return change**: -101.70 (-): worsening
- **Expected Return**: -9827.80%

### Recent News & Significant Events
--------------------------------------

[List of events not analyzed, please refer to concrete headlines for detailed information.]

### Analyst Opinions
-------------------

Analyst Consensus:
 Hold
 Mean (1=StrongBuy~5=Sell): 2.67
 Opinions: 22
 Target Price (avg/high/low): $9.06 / $12.00 / $7.00

### Recent Earnings Analysis
---------------------------

| Date  | EPS | Revenue |
|-------|-----|---------|
| 2025-10-30 | -0.28 | $0.63B  |
| 2025-07-30 | -0.19 | $0.63B  |
| 2025-05-01 | -0.53 | $0.63B  |
| 2024-10-31 | -0.19 | $0.64B  |
| 2025-10-30 | -0.19 | $0.64B  |

TDOC reported consecutive declining EPS and Revenue in 2024-2025, indicating possible difficulties in maintaining its financial performance.

### Financial Information
-----------------------

Revenue and Profitability:

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $0.63B | 70.12%         |
| 2025-06-30 | $0.63B | 69.85%         |
| 2025-03-31 | $0.63B | 68.73%         |
| 2024-12-31 | $0.64B | 70.50%         |
| 2024-09-30 | $0.64B | 71.94%         |

Capital and Profitability:

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $1.39B | -3.56% |
| 2025-06-30 | $1.42B | -2.30% |
| 2025-03-31 | $1.43B | -6.52% |
| 2024-12-31 | $1.49B | -3.25% |
| 2024-09-30 | $1.51B | -2.21% |

Declining profit margin, negative equity growth and decreasing return on equity (ROE) indicate Teladoc Health Inc's struggle to maintain its profitability.

### Comprehensive Analysis (Summary)
------------------------------------------

TDOC underperformed S&P 500 by significant margins, showed poor earnings growth, and struggled with profitability issues, including declining profit margins, negative equity growth, and decreasing return on equity (ROE). Technical indicators, including RSI and PPO, showed signs of uncertainty and potential weakness in the stock. Considering all the negative trends, caution is advised when considering a long-term investment.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.